Contact
Please use this form to send email to PR contact of this press release:
Cardiol Therapeutics Expands LANCER, a Phase II/III Trial of CardiolRxTM, into Brazil, Mexico, and Canada
TO:
John Todora
FinPub Solutions
+1 412-509-3055